主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ELVN
#1718
Enliven Therapeutics, Inc. Common Stock
29.690
0
+2.63%
版块:
基础:
利润货币:
日范围
年范围
日变化
+2.63%
每月变动
+13.58%
6个月变化
+43.71%
年变化
+43.71%
前一天收盘价
28.930
0
Open
29.700
0
Bid
Ask
Low
29.690
0
High
29.700
0
交易量
140
市场
股票
医疗保健
ELVN
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
17.58 M
26.29 M
26.23 M
41.35 M
49 M
—
Valuation ratios
Enterprise value
—
—
—
515.94 M
978.48 M
4.02 B
Price to earnings ratio
—
—
—
-7.41
-11.9
-43.31
Price to sales ratio
—
—
—
—
96.28 K
—
Price to cash flow ratio
—
—
—
8.64
14.47
56.17
Price to book ratio
—
—
—
2.15
3.42
5.64
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.46
0.55
0.02
0.26
0.27
0.26
Return on equity %
0.49
0.6
0.02
0.29
0.29
0.27
Return on invested capital %
51.61 K
33.32 K
156.69
2 319.69
1 935.13
2 536.97
Gross margin %
—
—
100
—
100
—
Operating margin %
—
—
4 562.5
—
950.49 K
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
9 300
—
809.31 K
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
14.47
12.86
48.98
10.28
19.99
106.58
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
0
—
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
1.35
1.72
1.55
1.39
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
3.34
7.12
6.66
29.55
Net current asset value per share
—
—
3.4
7.49
6.76
29.92
Tangible book value per share
—
—
3.42
6.92
6.58
29.38
Working capital per share
—
—
3.33
6.76
6.42
28.78
Book value per share
—
—
3.42
6.92
6.58
29.38
新闻
Enliven Therapeutics董事Heyman出售3.2万美元股票
Heyman, Enliven Therapeutics director, sells $32k in stock
Lyssikatos,Enliven Therapeutics首席科学官出售价值14.5万美元股票
Lyssikatos, Enliven Therapeutics CSO, sells $145k in shares
Lyssikatos, Enliven Therapeutics CSO, sells $535k in ELVN stock
Enliven Therapeutics董事Heyman出售价值32,901美元的股票
Enliven Therapeutics director Heyman sells $32,901 in stock
Enliven Therapeutics首席运营官Anish Patel出售价值135万美元ELVN股票
Anish Patel, COO of Enliven Therapeutics, sells $1.35m in ELVN
Enliven Therapeutics: Springing Into 2026 With Data, But I'm Still Cautious
Enliven Therapeutics首席科学官Lyssikatos出售价值347万美元股票
Enliven Therapeutics CSO Lyssikatos sells $3.47 million in shares